Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang Biotech Investing
C4 Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Pfizer for the Combination of Cemsidomide and Elranatamab for the Treatment of Relapsed/Refractory Multiple Myeloma Biotech Investing
Medicenna Therapeutics to Participate in the ROTH 4th Annual Healthcare Opportunities Conference Biotech Investing
Bristol Myers Squibb's Anti-MTBR-Tau-Targeting Antibody, BMS-986446, Granted Fast Track Designation by U.S. FDA for the Treatment of Alzheimer's Disease Pharmaceutical Investing
Telo Genomics Expands Operations with Relocation of Clinical Laboratories to New, Larger Toronto Facility and Provides Board Update Genetics Investing
AbbVie Begins Construction on $70 Million Expansion to Further Increase Biologics Manufacturing and R&D Presence in the U.S. Pharmaceutical Investing
Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients Pharmaceutical Investing
HCW Biologics Inc. Participates in Virtual Investor "What This Means" Segment About its Proprietary T-Cell Engager Program Biotech Investing
